Dxn Stock

Dxn ROE

The Return on Equity (ROE) of Dxn (DXN.AX) as of Aug 1, 2026 is -47.04 %. In the previous year, Return on Equity (ROE) was 558.62 % — a change of -108.42% (lower).

ROE

-47.04 %

YoY

-108.42%

Last updated:

In 2026, Dxn's return on equity (ROE) was -47.04 %, a -108.42% increase from the 558.62 % ROE in the previous year.

Access this data via the Eulerpool API

Dxn Stock analysis

What does Dxn do? DXN Ltd is a leading global company in the health and wellness industry, headquartered in Malaysia. The company was founded in 1993 by Dato' Dr. Lim Siow Jin, who developed a revolutionary business model to offer high-quality dietary supplements and healthy beverages. The goal was to enable people worldwide to have a better and healthier life. The history of DXN Ltd began over 25 years ago when Dato' Dr. Lim Siow Jin discovered his passion for herbal medicine and started researching medicinal mushrooms. Initially, it was difficult to garner people's interest in herbal medicine. However, over time, the company became increasingly successful and interest in its products grew. DXN Ltd has developed a unique business model that allows people to build a business in the health and wellness industry while selling healthy products. DXN refers to this as the "One Dragon, One World, One Market" concept. This means that DXN focuses on selling products based on natural ingredients and markets them through a network of distributors worldwide. DXN Ltd offers various product lines. One of its most well-known products is "Lingzhi Coffee," which is made from natural ingredients and contains all the benefits of "Lingzhi," a medicinal mushroom. The company also offers other coffee varieties, tea, dietary supplements, and skincare products. The dietary supplements offered by DXN Ltd are based on natural ingredients such as mushrooms and herbs. Each product is carefully manufactured and tested to ensure the highest quality. DXN Ltd has received many patents for its products and is known for its innovative offerings. The company also provides a comprehensive training program for its distributors to ensure that they understand the products and the business model and can market them successfully. DXN Ltd has built a global network of distributors registered in over 180 countries. DXN Ltd has received many awards for its products and business model. It has been named "Company of the Year" by Direct Selling News Magazine and has also received the "Reader's Digest Asia Trusted Brand Award" for its outstanding products and services. DXN Ltd is committed to continued growth and expanding its range of healthy products. The company also actively promotes environmental protection and engages in various charitable activities to give back to society. In summary, DXN Ltd is an innovative and future-oriented company dedicated to promoting a healthy and better life for people worldwide. With its high-quality products and unique business model, the company has achieved a strong position in the health and wellness industry. Dxn is one of the most popular companies on Eulerpool.

ROE Details

Decoding Dxn's Return on Equity (ROE)

Dxn's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Dxn's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Dxn's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Dxn’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Dxn stock

Return on Equity (ROE) of Dxn is -47.04 % in 2026.

Access this data via the Eulerpool API

Profitability — Dxn

All Key Metrics — Dxn